1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007. 175:367–416.
2. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis. 1988. 137:1280–1284.
Article
3. Evans AJ, Crisp AJ, Hubbard RB, Colville A, Evans SA, Johnston ID. Pulmonary
Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. Thorax. 1996. 51:1243–1247.
Article
4. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002. 23:553–567.
5. Falkinham JO 3rd. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002. 23:529–551.
Article
6. Ahn CH, McLarty JW, Ahn SS, Ahn SI, Hurst GA. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis. 1982. 125:388–391.
7. Johanson WG Jr, Nicholson DP. Pulmonary disease due to Mycobacterium kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis. 1969. 99:73–85.
8. Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Hurst GA. Radiographic manifestations of pulmonary Mycobacterium kansasii infections. AJR Am J Roentgenol. 1978. 131:985–993.
9. Shitrit D, Baum GL, Priess R, Lavy A, Shitrit AB, Raz M, et al. Pulmonary
Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Chest. 2006. 129:771–776.
Article
10. Griffith DE, Brown-Elliott BA, Wallace RJ Jr. Thrice-weekly clarithromycin-containing regimen for treatment of
Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis. 2003. 37:1178–1182.
Article
11. Shitrit D, Priess R, Peled N, Bishara G, Shlomi D, Kramer MR. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome. Eur J Clin Microbiol Infect Dis. 2007. 26:679–684.
12. Koh WJ, Kwon OJ, Lee KS. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective. J Korean Med Sci. 2005. 20:913–925.
Article
13. Lee JY, Choi HJ, Lee HY, Joung EY, Huh JW, Oh YM, et al. Recovery rate and characteristics of nontuberculous mycobacterial isolates in a university hospital in Korea. Tuberc Respir Dis. 2005. 58:385–391.
Article
14. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006. 129:341–348.
Article
15. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal. 2008. 22:415–420.
Article
16. Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim H, Lee NY, et al. A case report of three patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium kansasii. Tuberc Respir Dis. 2003. 54:459–466.
17. Yim JJ, Park YK, Lew WJ, Bai GH, Han SK, Shim YS. Mycobacterium kansasii pulmonary diseases in Korea. J Korean Med Sci. 2005. 20:957–960.
18. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000. 161:1376–1395.
19. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008. 246:697–722.
20. Koh WJ, Yu CM, Suh GY, Chung MP, Kim H, Kwon OJ, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis. 2006. 10:1001–1007.
21. Kobashi Y, Matsushima T, Oka M. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med. 2007. 101:130–138.
22. Anderson DH, Grech P, Townshend RH, Jephcott AE. Pulmonary lesions due to opportunist mycobacteria. (Review includes 30 cases of M. kansasii infections). Clin Radiol. 1975. 26:461–469.
23. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with
Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax. 1983. 38:271–274.
Article
24. Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Anderson J, et al. Initial roentgenographic manifestations of pulmonary Mycobacterium tuberculosis, M kansasii, and M intracellularis infections. Chest. 1981. 80:132–136.
25. Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest. 1979. 75:120–125.
26. Igari H, Kikuchi N. Nontuberculous Mycobacterium pulmonary infection with pleural effusion caused by Mycobacterium kansasii. Kekkaku. 1993. 68:527–531.
27. Kamiya H, Toyota E, Kobayashi N, Kudo K. A case of pulmonary Mycobacterium kansasii infection complicated with pleural effusion. Kekkaku. 2004. 79:397–400.
28. Olafsson EJ, Naum CC, Sarosi GA, Mastronarde JG. Bilateral pleural effusions and right pneumothorax in a 25-year-old man. Chest. 2004. 126:986–992.
29. Sauret J, Hernández-Flix S, Castro E, Hernández L, Ausina V, Coll P. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis. 1995. 76:104–108.
30. Santin M, Dorca J, Alcaide F, Gonzalez L, Casas S, Lopez M, et al. Long-term relapses after 12-month treatment for
Mycobacterium kansasii lung disease. Eur Respir J. 2009. 33:148–152.
Article